Email This Article

Headlines & Perspectives
FDA Backlog Leaves Biotech Stocks in Limbo
By Adam Feuerstein
03/25/08 - 06:57 AM EDT
A lack of resources leads the agency to push back drug approval deadlines, adding murkiness to an already tricky sector.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,423.36 1,112.61 2,203.62 33.51
Oil *
78.73
UP
152.89
UP
19.13
UP
35.74
DOWN
0.78
10 Yr
3.35%
SPDR Gold
112.08
+1.49%
+1.75%
+1.65%
-2.27%
Data delayed 20 minutes

Brokerage Partners